Mathieu Uhart

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study.

Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study.

Journal: Open forum infectious diseases

Published: February 17, 2025

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France.

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France.

Journal: Human vaccines & immunotherapeutics

Published: November 14, 2024

New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.

New Vaccine Platforms-Novel Dimensions of Economic and Societal Value and Their Measurement.

Journal: Vaccines

Published: January 17, 2024

Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018.

Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018.

Journal: Influenza and other respiratory viruses

Published: December 14, 2021

Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.

Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.

Journal: Vaccine

Published: March 24, 2020

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.

Journal: PloS one

Published: July 08, 2019

Epidemiological and economic burden of potentially HPV-related cancers in France.

Epidemiological and economic burden of potentially HPV-related cancers in France.

Journal: PloS one

Published: March 07, 2018

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.

Journal: Cost effectiveness and resource allocation : C/E

Published: August 05, 2016

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France.

Journal: Papillomavirus research (Amsterdam, Netherlands)

Published: July 18, 2016

An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.

An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: July 02, 2016

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.

Journal: Human vaccines & immunotherapeutics

Published: May 12, 2016

The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older.

The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older.

Journal: Journal of medical economics

Published: January 26, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026